ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.305,57
-0,34%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,1672
0,56%
Bitcoin
69.076,39
-0,28%
Brent Oil
81,965
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Synergy Pharmaceuticals, Inc. (SGYP)

  7. Synergy Pharmaceuticals, Inc. (SGYP) Notícias

SGYP

Synergy Pharmaceuticals, Inc. (SGYP)

Synergy Pharmaceuticals, Inc.
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SGYP
DataHoraFonteTítuloCódigoCompanhia
01/12/202104:00GlobeNewswire Inc.OKYO Pharma Limited: Directorate ChangeNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
02/05/201911:58Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
02/05/201911:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
06/03/201911:30PR Newswire (US)Synergy Pharmaceuticals Announces Completion of Sale to Bausch HealthNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
06/03/201911:00PR Newswire (Canada)Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
01/03/201921:13Dow Jones NewsSynergy Pharmaceuticals Is Approved to Sell Assets to Bausch HealthNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
01/03/201920:30PR Newswire (US)Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch HealthNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
26/02/201921:07Dow Jones NewsBausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
26/02/201920:00PR Newswire (US)Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business AssetsNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
12/02/201915:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
17/12/201818:43Dow Jones NewsSynergy Pharmaceuticals Up 55% on Trulance Progress in CanadaNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
12/12/201814:10Dow Jones NewsFormer Pharma Highflier Appreciates Bathroom Humor -- OverheardNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
12/12/201811:18Dow Jones NewsBausch Health to Buy Synergy Pharmaceuticals Out of Bankruptcy for $200 Million--UpdateNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
12/12/201810:14Dow Jones NewsBausch Health Agrees to Buy Synergy Pharmaceuticals for $200 MillionNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
12/12/201809:30PR Newswire (US)Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceut...NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
12/12/201809:00PR Newswire (US)Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business AssetsNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
15/11/201815:33Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
09/11/201812:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
08/11/201820:00Business WireSynergy Pharmaceuticals Reports Third Quarter 2018 Financial Results and Business UpdateNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
31/10/201818:00Business WireSynergy Pharmaceuticals Names Dr. Melvin K. Spigelman ChairmanNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
25/10/201818:00Business WireSynergy Pharmaceuticals Provides Business UpdateNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
08/10/201809:00Business WireSynergy Pharmaceuticals Presents New Analyses Supporting the Use of TRULANCE® (plecanatide) in Two Patient Populations at th...NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
01/10/201810:30Business WireSynergy Pharmaceuticals to Present New Analyses of TRULANCE® (Plecanatide) at the American College of Gastroenterology (ACG)...NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
24/09/201809:00Business WireSynergy Pharmaceuticals Strengthens Coverage for TRULANCE® (plecanatide) with Key New Market Access WinsNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
16/08/201818:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
07/08/201822:22Business WireCORRECTING and REPLACING Synergy Pharmaceuticals Reports Second Quarter 2018 Financial Results and Business UpdateNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
07/08/201818:00Business WireSynergy Pharmaceuticals Reports Second Quarter 2018 Financial Results and Business UpdateNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
07/08/201810:00Business WireSynergy Pharmaceuticals Announces TRULANCE® (plecanatide) Added to Express Scripts 2019 National Preferred Formulary ListNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
07/08/201807:00Business WireSynergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE® (plecanatide) in ChinaNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
13/06/201808:30Business WireSynergy Pharmaceuticals Announces Amendment to CRG Debt AgreementNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
 Apresentando as notícias mais relevantes sobre:NASDAQ:SGYP

Seu Histórico Recente

BOV
PRIO3
PETRORIO ON
BOV
IBOV
Índice Bovespa
BOV
POSI3
POSITIVO TEC ON
BOV
COGN3
COGNA ON
BOV
PDTC3
Padtec ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados